alpha-conotoxin imi has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, B; Mei, D; Ni, X; Wang, X; Yu, Z; Zhang, Q; Zhang, X; Zhao, L | 1 |
1 other study(ies) available for alpha-conotoxin imi and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer.
Topics: A549 Cells; alpha7 Nicotinic Acetylcholine Receptor; Animals; Carcinoma, Non-Small-Cell Lung; Conotoxins; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Micelles; Nanocapsules; Polymers; Random Allocation; Taxoids | 2018 |